therapy is indicated for secondary stroke
prevention in both large and small vessel disease.
This would include carotid artery, vertebrobasilar arteries, and the intracranial arteries. Current recommendations are for single agent therapy, but patients should be tested periodically with platelet aggregation tests to determine drug efficacy. No indications for primary prevention.